Clinical Trials

Showing trials with last updates posted in 2021.

NCT02270606 | COMPLETED | PHASE1
14 participants

Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2021-07-20
Start Date:
2014-12-04
Completion:
2018-05-14
Conditions
  • Mucinous Adenocarcinoma of the Rectum
  • Recurrent Rectal Cancer
  • Signet Ring Adenocarcinoma of the Rectum
  • Rectal Adenocarcinoma
  • Stage IIA Rectal Cancer
  • Stage IIB Rectal Cancer
  • Stage IIC Rectal Cancer
  • Stage IIIA Rectal Cancer
  • Stage IIIB Rectal Cancer
  • Stage IIIC Rectal Cancer
Interventions
  • RADIATION
  • DRUG
  • PROCEDURE
No Results Yet
NCT02261402 | COMPLETED | NA
1480 participants

Effectiveness of "Medisinstart"

Study Type:
INTERVENTIONAL
Last Updated:
2021-07-20
Start Date:
2014-10-31
Completion:
2015-12-31
Conditions
  • Cardiovascular Diseases
Interventions
  • OTHER
No Results Yet
NCT02162576 | COMPLETED | NA
95 participants

Asthma Data Innovation Demonstration Project

Study Type:
INTERVENTIONAL
Last Updated:
2021-07-20
Start Date:
2012-06-30
Completion:
2014-01-31
Conditions
  • Asthma
  • Bronchial Diseases
  • Respiratory Tract Diseases
  • Lung Diseases, Obstructive
  • Lung Diseases
  • Respiratory Hypersensitivity
  • Hypersensitivity, Immediate
  • Hypersensitivity
  • Immune System Diseases
Interventions
  • DEVICE
NCT01988506 | COMPLETED | PHASE2
81 participants

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

Study Type:
INTERVENTIONAL
Last Updated:
2021-07-20
Start Date:
2014-01-06
Completion:
2019-10-16
Conditions
  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Systemic Lupus Erythematosus
  • Psoriasis
  • Behcet's Disease
  • Wegener's Granulomatosis
  • Takayasu's Disease
  • Crohn's Disease
  • Ulcerative Colitis
  • Autoimmune Hepatitis
  • Sclerosing Cholangitis
  • Gougerot-sjögren
  • Idiopathic Thrombocytopenic Purpura
  • Systemic Sclerosis
Interventions
  • DRUG
No Results Yet
NCT01434472 | TERMINATED | PHASE2
20 participants

High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2021-07-20
Start Date:
2011-11-16
Completion:
2020-05-06
Conditions
  • Post-Transplant Lymphoproliferative Disorder
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • Recurrent Burkitt Lymphoma
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • Refractory Burkitt Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
Interventions
  • PROCEDURE
  • DRUG
  • RADIATION
  • OTHER
  • BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page